ArticleAgalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry
Under an Elsevier user license
open archive
Keywords
lysosomal storage disease
alpha galactosidase A deficiency
SF-36® Health Survey
enzyme replacement therapy
health status indicator
Cited by (0)
© 2010, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics